Novo Nordisk: Analysts react - | Stock starts rebound:
Subdued mood after the half-year report.
deraktionaer.de/artikel/pharma-biotech/novo-nordisk-analysten-reagieren-aktie-startet-rebound-20406356.html
Story Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
single unit of ownership in a corporation, mutual fund, or any other organization
Similar to This
Previous
Accenture is looking to sell Greater China business for up to $1.5 billion, FT report says
qz.com/accenture-greater-china-sale-jpmorgan-review-101926
Novo Nordisk: Too many factors speak against a quick turnaround: Novo Nordisk is one of the biggest beneficiaries of the boom in slimming drugs ...
themarket.ch/unternehmen/novo-nordisk-zu-viele-faktoren-sprechen-gegen-einen-baldigen-turnaround-ld.17608
Novo Nordisk: Too many factors speak against a quick turnaround: Novo Nordisk is one of the biggest beneficiaries of the boom in slimming drugs ...
themarket.ch/unternehmen/novo-nordisk-zu-viele-faktoren-sprechen-gegen-einen-baldigen-turnaround-ld.17608
Novo Nordisk: JPMorgan raises price target - | this promising company could shape the future
deraktionaer.de/artikel/pharma-biotech/novo-nordisk-jpmorgan-erhoeht-kursziel-dieser-hoffnungstraeger-koennte-die-zukunft-praegen-20407386.html
GLP-1 drugs are driving higher sales for Eli Lilly and Novo Nordisk: Sales of Mounjaro, Eli Lilly’s diabetes drug, rose 91 per cent in the second quarter of the ...
globalnews.ca/news/12010271/glp-1-drugs-higher-sales-pharmaceutical/
Hims & Hers Q1 2026 earnings: net loss, weak guidance: The telehealth company posted a net loss of $92 million in the first quarter as its shift away from ...
qz.com/hims-hers-net-loss-weight-loss-drug-pivot-051226
Stock surges: More than a million Americans are using the new Wegovy weight-loss pill
manager-magazin.de/unternehmen/pharma/novo-nordisk-aktie-mit-kurssprung-ueber-eine-million-nutzer-der-wegovy-abnehmpille-a-2e38aeaa-9b92-4e42-b274-c3b51c83a424
Novo Nordisk shares rise after Wegovy recommended by Britain's drug price regulator
cnbc.com/2026/04/01/novo-nordisk-stock-wegovy-ozempic-nice-nhs-nvo.html
Novo Nordisk: The calm before the storm?: Novo Nordisk is stabilizing, but analysts remain cautious. Goldman Sachs slightly raises its price target ...
deraktionaer.de/artikel/pharma-biotech/novo-nordisk-die-ruhe-vor-dem-sturm-20398206.html
Novo Nordisk makes a splash: Wegovy HD receives US approval - | Starting gun for the next rally?
deraktionaer.de/artikel/aktien/novo-nordisk-mit-paukenschlag-wegovy-hd-erhaelt-us-zulassung-startschuss-fuer-die-naechste-rally-20397611.html
Novo Nordisk: Many problems - | now also FDA reprimand: Novo Nordisk stock falls after FDA warning and unreported side effects, despite good Wegovy sales.
deraktionaer.de/artikel/aktien/novo-nordisk-viele-probleme-jetzt-auch-noch-fda-ruege-20397121.html
Novo Nordisk: Share price jump after Christmas - | or just another false signal?: Novo Nordisk shares rise after FDA approval for oral Wegovy version.
boerse-online.de/nachrichten/aktien/novo-nordisk-kurssprung-nach-weihnachten-oder-nur-wieder-ein-fehlsignal-20392699.html
Next